Shanghai Pharmaceuticals Holding Co (SHSE:601607) Other Operating Expense : ¥4,095 Mil (TTM As of Mar. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Shanghai Pharmaceuticals Holding Co Other Operating Expense?

Shanghai Pharmaceuticals Holding Co's Other Operating Expense for the three months ended in Mar. 2024 was ¥142 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥4,095 Mil.

Shanghai Pharmaceuticals Holding Co's quarterly Other Operating Expense increased from Sep. 2023 (¥-1,832 Mil) to Dec. 2023 (¥3,826 Mil) but then declined from Dec. 2023 (¥3,826 Mil) to Mar. 2024 (¥142 Mil).

Shanghai Pharmaceuticals Holding Co's annual Other Operating Expense increased from Dec. 2021 (¥3,713 Mil) to Dec. 2022 (¥3,784 Mil) and increased from Dec. 2022 (¥3,784 Mil) to Dec. 2023 (¥3,944 Mil).

Shanghai Pharmaceuticals Holding Co Other Operating Expense Historical Data

The historical data trend for Shanghai Pharmaceuticals Holding Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Pharmaceuticals Holding Co Other Operating Expense Chart

Shanghai Pharmaceuticals Holding Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

3,108.36

3,239.44

3,713.35

3,784.40

3,944.24

Shanghai Pharmaceuticals Holding Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															-8.59	1,959.04	-1,832.37	3,826.16	141.71

Shanghai Pharmaceuticals Holding Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥4,095 Mil.

Shanghai Pharmaceuticals Holding Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Shanghai Pharmaceuticals Holding Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Pharmaceuticals Holding Co (SHSE:601607) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Shanghai Pharmaceuticals Holding Co Ltd (SHSE:601607) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

SHPMY:USA SHPMF:USA 02607:Hong Kong S1R:Germany

Address

No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020

Website

https://www.sphchina.com

Shanghai Pharmaceuticals Holding is a vertically integrated Chinese healthcare company that operates drug manufacturing, distribution, and retail pharmacy businesses in mainland China. It is the second-largest distributor by revenue and has a strong distribution presence in Eastern China.

Shanghai Pharmaceuticals Holding Co (SHSE:601607) Headlines

No Headlines